Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...
Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...
Think you know the signs of prostate cancer? Discover the subtle urinary changes many men ignore that could be a vital early ...
Inherited CDK12 mutations may mark a rare but aggressive form of prostate cancer, helping identify families who could benefit ...
The metastatic castration-resistant prostate cancer market is poised for substantial growth over the coming years, driven by ...
A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine ...
NeoGenomics launched PTEN IHC CDx, the first IHC companion diagnostic test approved by the U.S. FDA for patients with ...
New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...
The 68-year-old previously told how his diagnosis came as a 'real bolt from the blue' ...
CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...
When I had my prostate removed in September 2023, I believed the worst was behind me. After months of tests, scans and ...
For better cancer care in India, Novartis India has announced the launch of Pluvicto (lutetium (177Lu) vipivotide tetraxetan), the country’s first regulatory authority approved radioligand therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results